Platform & Products

Our platform enables efficient development of personalised medicine products by integrating drugs and devices with patient-led digital experiences to support patients with long term conditions.

Creating closed loop models of care

  • Drug

    Optimising dosing and medication regimens using personalised information and feedback.

  • Digital

    Providing a software platform to coach, support, and guide each patient’s journey to good health. Delivering unique insights to improve patients’ care.

  • Device

    Harnessing data captured by medical devices, smartphones and wearables to support disease management and recovery.

How it works

Medication and digital therapies available through a single prescription.

Platform

Our platform connects patients, clinicians and carers. It provides standard components that can be customised to develop combined medication and digital therapy products that employ precision medicine to help patients reach better outcomes.

Payor

Our products aim to improve treatment outcomes. We want to improve patient access to precision dosing, behavioural therapy and wellness programmes. This benefits payors by reducing costs of disease management.

Pharma

Medications can be combined with digital products and existing software services. This allows value to be added to existing products to improve efficacy and uptake. By collecting data on real world use, continual improvement and label expansion is made possible.

Patient

Patients receive medications and digital therapies managed on their smartphone. This places the patient at the centre of their treatment enabling effective and safe dosing. This minimises side effects, encourages adherence and maximises treatment efficacy.

Carer

In certain use cases, to improve treatment outcomes, patients can choose to share their data with other people involved in their support network.

Clinician

Data and recommendations are shared with clinicians so they can make informed treatment decisions at an individual patient level. Collecting data between appointments means patient and clinician interactions can be optimised to improve appointment productivity.

Platform
Payor
Pharma
Patient
Carer
Clinician

How it works

Medication and digital therapies available through a single prescription.

Platform
Payor
Pharma
Patient
Carer
Clinician

Our platform connects patients, clinicians and carers. It provides standard components that can be customised to develop combined medication and digital therapy products that employ precision medicine to help patients reach better outcomes.

Our products aim to improve treatment outcomes. We want to improve patient access to precision dosing, behavioural therapy and wellness programmes. This benefits payors by reducing costs of disease management.

Medications can be combined with digital products and existing software services. This allows value to be added to existing products to improve efficacy and uptake. By collecting data on real world use, continual improvement and label expansion is made possible.

Patients receive medications and digital therapies managed on their smartphone. This places the patient at the centre of their treatment enabling effective and safe dosing. This minimises side effects, encourages adherence and maximises treatment efficacy.

In certain use cases, to improve treatment outcomes, patients can choose to share their data with other people involved in their support network.

Data and recommendations are shared with clinicians so they can make informed treatment decisions at an individual patient level. Collecting data between appointments means patient and clinician interactions can be optimised to improve appointment productivity.

Pipeline

Programme Research & Development Clinical Evaluation Regulatory Submission Product Launch

CLM-IN01

Insomnia

CLM-HT01

Hypertension

CLM-P01

Chronic Pain

Programme Current status

CLM-IN01

Insomnia

Regulatory Submission

CLM-HT01

Hypertension

Clinical Evaluation

CLM-P01

Chronic Pain

Research & Development

CLM-IN01

Insomnia

A single label combination product combining the Company’s UKCA / CE approved medical device software product for insomnia with a novel prolonged release micro-granule drug formulation.

Stage:

Regulatory Submission

Key Milestones:

Bioequivalence secured, UKCA and CE marking secured

Latest News:

The product is currently in the last phase of clinical development prior to regulatory submission.

CLM-IN01

Insomnia

CLM-HT01

Hypertension

A single label combination product linking a medical device software product designed to support patients in the management of their blood pressure through the identification of a personalised dosing regimen with integrated wellness and behaviour content with a first in line anti-hypertensive.

Stage:

Clinical Evaluation

Key Milestones:

Clinical studies completed in the US and underway in the UK

Latest News:

The product has undergone initial clinical development in the USA and is currently under evaluation in a clinical study with Queen Mary University London and Bart’s Health Trust.

CLM-HT01

Hypertension

CLM-P01

Chronic Pain

A single label, medication and medical device software product for patients with Chronic Pain.

Stage:

Research & Development

Key Milestones:

Prototype

Latest News:

Early development work initiated with technology partners to identify safe ways of supporting patients with chronic pain.

CLM-P01

Chronic Pain